Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
638 studies found for:    eczema
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema
Condition: Eczema
Interventions: Drug: LAS41003;   Drug: LAS189962;   Drug: LAS189961
22 Withdrawn Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy
Condition: Atopic Dermatitis
Interventions: Drug: Altabax (R);   Drug: Vehicle and Locoid lipocream (R)
23 Completed Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
Conditions: Atopic Dermatitis;   Eczema Herpeticum
Intervention:
24 Completed Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
Conditions: Atopic Dermatitis;   Atopic Eczema;   Infantile Eczema;   Hand Eczema
Intervention: Other: Patient Educational Materials
25 Completed
Has Results
Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.
Condition: Atopic Dermatitis
Interventions: Drug: QAW039;   Drug: Placebo
26 Unknown  Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
Conditions: Dermatitis, Atopic;   Eczema
Interventions: Drug: Desonide Cream;   Other: Amino Acid Moisturizing Cream
27 Completed DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study
Condition: Eczema
Intervention: Other: DEC033 Study Product
28 Completed A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: PH-10
29 Completed Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis
Conditions: Dermatitis, Atopic;   Eczema
Interventions: Drug: Investigational OTC Cream;   Other: Cosmetic Eczema Cream;   Drug: 0.05% Desonide Cream;   Other: Placebo Cream
30 Recruiting 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
Condition: Atopic Dermatitis
Intervention: Drug: Pimecrolimus
31 Active, not recruiting A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib;   Drug: Placebo;   Drug: Triamcinolone (Optional)
32 Recruiting Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema
Condition: Chronic Eczema
Interventions: Drug: Runzao zhiyang capsule;   Drug: Runzaozhiyang capsule agent simulation;   Drug: Urea cream
33 Completed Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema
Condition: Hand Eczema
Interventions: Drug: LEO 124249 ointment;   Drug: LEO 124249 ointment vehicle
34 Recruiting Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
Conditions: Dermatitis, Atopic;   Eczema
Intervention: Behavioral: Self help intervention
35 Completed Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema
Condition: Atopic Dermatitis
Interventions: Device: EpiCeram Skin Barrier Emulsion;   Drug: Experimental Product 1% Colloidal Oatmeal Balm
36 Completed Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: MEDI9929;   Biological: Placebo
37 Completed Treatment of Staphylococcus Aureus Colonization in Hand Eczema
Conditions: Hand Eczema;   Foot Eczema
Interventions: Drug: Retapamulin 1% ointment;   Drug: Placebo
38 Completed Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Condition: Eczema
Interventions: Drug: alitretinoin;   Drug: Placebo
39 Completed Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis
Conditions: Eczema;   Atopic Dermatitis
Intervention: Device: Elidel (pimecrolimus cream, 1%) Hylatopic Plus Emollient Foam (non-medicated device)
40 Completed The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants
Condition: Atopic Dermatitis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.